Dr. Gurneet Singh Bedi, MD

Dr. Bedi practices at West Central Gastroenterology in Saint Petersburg, Florida.

Dr. Bedi's NPI, 1528402542, was assigned on April 21, 2013. Dr. Bedi graduated from Ross University School of Medicine in 2013. Dr. Bedi holds New York license 299625.

Dr. Bedi's primary practice is West Central Gastroenterology, at 1201 5th N Ave, Saint Petersburg, FL 33705 in Pinellas County. The practice phone is (727) 347-0005.

Dr. Bedi's primary practice is West Central Gastroenterology in Saint Petersburg, Florida. Dr. Bedi is also affiliated with BayCare St. Anthony's Hospital. The medical group on file is Gastro Florida. Dmand AI also links Dr. Bedi to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedi practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bedi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bedi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bedi's licenses on file in 3 states: New York, Florida and Pennsylvania.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Bedi treats.

CMS data shows 919 Medicare services from Dr. Bedi across 13 procedure codes in 2024, for 422 Medicare patients. Medicare paid $90,606 for them.

CMS counts 422 Medicare patients who saw Dr. Bedi in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bedi's median patient age at 63, with 56% women.

In 2024, Dr. Bedi wrote 635 Medicare Part D claims for 285 patients. 71% of them were for generic drugs. CMS names the drug for 493 of them, across 12 drugs with 11 or more claims each, at $251,333 in total drug cost. In 2023, CMS named 404 claims across 10 drugs.

Dr. Bedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 211 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bedi, more than 91% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Bedi, published from 2016 to 2017. Dr. Bedi's most frequent co-authors are Donald P. Atkinson, MD, Charles Bulathsinghala, MD and Sierra Mei Lin Centkowski, MD.

CMS Open Payments shows 309 general payments to Dr. Bedi from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Micro-tech Endoscopy USA, Inc. paid the most, $3,536.

Dmand AI lists 1 award for Dr. Bedi, most recently AudioVisual Crystal Award in 2019. Dr. Bedi serves on Foundation for Interventional and Therapeutic Endoscopy.

Dr. Bedi graduated from Ross University School of Medicine in 2013.

Dr. Bedi is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.